• <td id="xvtus"><strike id="xvtus"></strike></td>

    About Us

    Overview of Xiangya Hospital of Central South University

    Founded in 1906 and located in Changsha, Xiangya Hospital of Central South University is a Class-A Grade-3 (top level in China) general hospital under direct supervision of the National Health Commission of China, and affiliated to Central South University directly under the Chinese Ministry of Education. It serves as an important center for clinical care, medical education and scientific and technological innovation in China, and enjoys a good reputation at home and abroad for its superior techniques of diagnosis and treatment, outstanding scientific and educational strength, and profound cultural background.

    Century-old Xiangya Originated from Yale University

    At the beginning of the 20th century, the establishment of the Yale-China Association by alumni of Yale University took an important step in running hospitals and schools in China. In 1906, American M.D. Edward H. Hume (18761957) was appointed to China by the Yale-China Association and founded Yale Hospital in Xipailou Street, Changsha. In 1914, entrusted by the Hunan provincial government, the Yuqun Society collaborated with the Yale-China Association in setting up Xiangya Medical School, the first higher medical education institution jointly established by Chinese and American resources. Yale Hospital was then renamed Hsiangya (Xiangya) Hospital. “Hsiang (Xiang)” refers to Hunan and “ya” is the transliteration of Yale.

    Invigorating Medical Cause to Revitalize the Chinese Nation

    Since its inception, Xiangya Hospital has integrated the highest European and American standards into its running philosophy. Starting from an old building in Xipailou Street, Changsha, it has evolved into a well-known general hospital in China after years of hard work and progress, fostering a number of highly reputed medical scientists, including Zhang Xiaoqian, one of the founding members of the Chinese Academy of Sciences and known as the “leading authority of Peking Union Medical College Hospital and Xiangya Hospital”, medical microbiologist Tang Feifan, and China-US exchange envoy Li Zhenpian.

    After the founding of the People’s Republic of China, Xiangya Hospital has unswervingly safeguarded the people’s health and made continuous breakthroughs in difficult and severe diseases, growing into a pioneer in many areas in China: the first hospital treating fasciolopsiasis with traditional Chinese medicine, the first with success in diagnosis of bronchogenic carcinoma by needle biopsy, the first completing allogeneic heterotopic partial liver transplantation, the first practicing allogeneic single lung transplantation under extracorporeal circulation, the first performing total pelvic exenteration via laparoscope, the first performing intraspinal subdural neurilemmoma excision under endoscope, the first cloning the pathogenic GJB3 gene of hereditary hearing loss, the first repairing severely burned hand by retaining denatured dermis and transplanting large autologous skin, the first performing thoracoabdominal aortic replacement with artificial blood vessel under left heart bypass, the first diagnosing and treating primary cerebral folate deficiency caused by rare gene mutations, the first  performing total laparoscopic pancreaticoduodenectomy assisted by MR technology, the first for "IMIE smart visual implant" surgery, the first performing robot-assisted resection of lung tumor, the first using γ-globin reactivation technique to treat patients with β0 / β0 severe thalassemia, the first applying two precise omics technologies to help patients with monogenic diseases get pregnant, the first using dual-pathway islet cell transplantation combined with kidney transplantation in the treatment of patients with Type 2 diabetes and renal failure, and the first treating lower extremity lymphedema with vascularized gastroepiploic lymph node flap transplantation. These achievements have greatly enhanced the development of medical undertakings. Xiangya takes a leading position in China in the research, diagnosis and treatment of neurological tumors, neurodegenerative diseases, melanoma, osteoarthritis, microsurgery, and so on.

    For over 110 years, Xiangya people has made tremendous contributions to the development of western medicine in China with their persistent ambition, noble medical ethics, rigorous style and practices, and superb skills.

    Staying True to the Original Aspiration and Striving for Excellence

    After entering the new era, Xiangya Hospital has practiced the hospital motto of “Fairness, Bravery, Diligence, Prudence, Honesty, Love, Humbleness, and Integrity”, the ethos of “Truth, Precision, Profoundness and Professionalism”, the mission of “Theoretical Contributions to Medical Science, Great Achievements in Healthcare, and Noble Morals for Lives”, the value of “Self-improvement with Innovation and Self-pursuit of Rigorousness and Harmony”, and the vision of “Growing into a World-class Hospital with Xiangya Characteristics to the Satisfaction of the People”. It has made great progress in medical services, discipline building, talent training, scientific and technological innovation and other fields. It ranks sixth in the performance evaluation of tertiary public hospitals across the country, and is selected as one of the pilot projects of national public hospitals for high-quality development, and undertakes the pilot task of establishing and improving the modern hospital management system.

    Xiangya has remarkable capability in clinical diagnosis and treatment. Covering a gross floor area of 510,000 m2 and with 3,500 beds registered, it received 3.473 million outpatients and emergency visits, discharged 160,000 inpatients, and performed 102,000 operations in 2021. It sets up 111 clinical and medical technology departments including sub-specialty departments, 77 inpatient wards and 102 nursing units. It works with the National Health Commission of China and the Hunan Provincial Government to build national and regional comprehensive, neurological, orthopedic, respiratory, and geriatric medical centers. In addition, it has seven national-level key disciplines and 25 national-level key clinical specialties, with several specialties, such as neurology, neurosurgery, dermatology, orthopedics, respiratory medicine, and geriatrics, ranking among the top in China in terms of diagnosis and treatment levels and scientific and technological influence. Equipped with PET-MRI, PET-CT, MRI, digital subtraction angiography (DSA), TOMO, BrainLab neuronavigational system, Da Vinci surgical robot, and other advanced medical equipment, Xiangya has leading-edge facilities and care quality in China.

    Xiangya has a high-caliber team of medical talent, including 4,902 technical personnel (897 with senior technical titles). 82% of physicians hold a doctoral degree. Currently it has 160 doctoral supervisors, 419 master’s supervisors, 1 academician of the Chinese Academy of Engineering, 47 state-level talent program winners, 2 state-level outstanding teachers, 7 young and middle-aged experts with outstanding contributions recognized by the National Health Commission, 69 professors enjoying special allowance of the State Council and 11 teachers supported by the Program for New Century Excellent Talents in University launched by the Ministry of Education.

    Xiangya has extraordinary medical education strength. With complete systems for undergraduate and postgraduate degree education, residency and fellowship training (graduate medical education), and further education and continuing medical education, it has been selected as one of the first national demonstration centers for clinical teaching and training, is one of the first members of China Consortium of Elite Teaching Hospitals for Residency Education, and has the largest number of approved specialist training bases in China. It offers five national quality courses, four national quality open courses and three national first-class undergraduate courses. In the past five years, it has edited 15 national-level teaching materials for universal use published by People’s Medical Publishing House, Higher Education Press, and other publishing houses. It has won the special award in the national clinical skills competition for medical college students and the first prize in the medical group of the 5th national teaching competition for young teachers in colleges and universities. It has regularly undertaken the task of training medical talent for western China.

    Xiangya is in the leading position with its high level of scientific and technological innovation. It ranks 4th in China and 73rd in the world among research-oriented hospitals and ranks 8th in terms of the 5-year Accumulative Science and Technology Evaluation Metrics (ASTEM) among all Chinese hospitals. It has four national scientific research platforms, namely, the National Clinical Research Center for Geriatric Disorders, the International Joint Research Center for Medical Metabolomics, the State-Local Joint Engineering Laboratory for Anti-cancer Drugs, the International Joint Research Center of Minimally Invasive Endoscopic Technology Equipment & Standardization, and 57 key laboratories and research centers at the provincial and ministerial levels. It hosts eight academic journals in Chinese and two in English. In the past five years, Xiangya Hospital has 589 projects approved by the National Natural Science Foundation of China, in addition to 3,320 research projects of various types, with the research fund totaling RMB 1.397 billion. It has published many research achievements in top academic journals, such as Science, JAMA, NEJM, and Lancet, as the first (corresponding) author’s affiliation. It has also won 40 national and provincial scientific and technological achievement awards.

    Manifesting True Quality from Public Benefit Activities

    As a public hospital, Xiangya Hospital regards public interest as a priority. It takes the lead in building a “Xiangya Model” health alliance integrating cooperative hospital running, collaborative guidance, remote guidance, specialty alliance, aviation medical alliance, and regional integrated medical system, and is the first in China establishing an internet hospital for dermatology. By promoting easier access to quality medical resources, it is growing stronger in leading the improvement of the regional medical level.

    With love and concern for people’s health and well-being, Xiangya people have shown their sense of responsibility in poverty alleviation, assistance to specific areas, aid to border areas and foreign countries, emergency rescue, earthquake relief, and the battle against the COVID-19 pandemic. It has been awarded many honorary titles such as “Top 100 Hospital in China” and “Trustworthy Demonstration Hospital”.

    In recent years, Xiangya has sent 17 national medical teams to carry out activities such as medical tours and "Action for the Health of the People" in Lvliang (Shanxi), Yanbian Korean Autonomous Prefecture (Jilin), Bijie (Guizhou), Diqing Tibetan Autonomous Prefecture (Yunnan), and Hechi (Guangxi). It led the formation of two groups of medical teams that helped Sierra Leone fight against Ebola, and achieved the goal of "zero infection (of medical staff), 100% cure rate (of patients received)". In addition, it pioneered the building of a national health emergency mobile medical treatment center and leveraged its mode of integrating medical services, education, research, and prevention to build it as a benchmark for health emergency response.

    In the fight against COVID-19, Xiangya Hospital put its major energies in Hunan and Hubei provinces by focusing on the treatment of patients with severe or critical conditions, nosocomial infection control, and routine medical care. It sent 142 medical workers to support the epidemic prevention and control in Hubei province and achieved outstanding results including no medical workers being infected, and was invited to share its experience at the press conference of the Joint Prevention and Control Mechanism of the State Council. It was also awarded the titles of the national advanced group and individuals in the fight against COVID-19 in recognition of its significant contribution.

    Striving Toward a First-class Hospital

    Carrying on glories inherited for a century, Xiangya Hospital will continue to pursue truth in the medical domain and draw another great picture. Under the guidance of the Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, Xiangya Hospital fully implements the guiding principles of the 19th CPC National Congress and all plenary sessions of the 19th CPC Central Committee. Following the Party's policies on health, scientific and technological innovation, and higher education in the new era, centering around people's health, and adhering to the principle of accelerated, leapfrog, connotative and high-quality development, Xiangya Hospital has vigorously implemented the "12368" development strategy (1 vision, 2 tasks, 3 goals, 6 features, 8 systems) and advanced the "3354" high-quality development mode (3 bases, 3 goals, 5 requirements, 4 approaches). In addition, it practices the value concept of Xiangya culture in the new era and the new development concept, plays its part in the new development pattern, and improves its service quality, comprehensive strength, and social reputation. It contrives to build itself into a world-class hospital with Xiangya characteristics to the satisfaction of the people, so as to make greater contributions to the cause of human health.

    (Data as of June 2022)

    Xiangya Hospital Central South University
    All Rights Reserved